Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06637644 · ClinicalTrials.gov registry record
Impella RP Flex with Smart Assist
A clinical trial of Right Ventricular (RV) Dysfunction, sponsored by Abiomed.
- Recruiting
- Registry status
- 200
- Enrollment target
- 20
- Study locations
NCT06637644: Recruiting study of Right Ventricular (RV) Dysfunction, sponsored by Abiomed.
NCT06637644 is a study of Right Ventricular (RV) Dysfunction that is actively recruiting participants, run by Abiomed. The registered enrollment target is 200 participants. The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06637644, a study of Right Ventricular (RV) Dysfunction, is actively recruiting participants, sponsored by Abiomed.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 20
- Study locations
Study Summary
To capture observational data of the Abiomed Impella RP Flex in a real-world setting.
Primary Outcome
Survival at hospital discharge, with follow-ups at 30 days, 90 days, and 1-year post-discharge of Impella RP patients from real-world surveillance data.
Conditions Studied
Interventions
- DEVICE Right-sided ventricular assist device
Study Locations (20)
Arkansas
- Baptist Health Heart Failure and Transplant Institute - Little Rock
- Arkansas Heart Hospital - Little Rock
Florida
- Advent Health Orlando - Orlando
- Tampa General - Tampa
Michigan
- Henry Ford Hospital - Detroit
- Ascension St. John Hospital - Detroit
New York
- Northwell Health/Lenox Hill Hospital - New York
- Montefiore Medical Center - Moses - The Bronx
North Carolina
- Novant Health New Hanover Regional Medical Center - Wilmington
- Wake Forest University School of Medicine - Winston-Salem
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Pima Heart and Vascular - Tucson
California
- University of Southern California (Keck USC) - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-05-29 |
| Est. Completion | 2026-06-01 |
What NCT06637644 shows while recruiting
NCT06637644 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Right Ventricular (RV) Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Right-sided ventricular assist device is the first listed.
NCT06637644 names 20 study sites across 15 states, led by Arkansas, Florida, Michigan.
Frequently Asked Questions
What is clinical trial NCT06637644 about?
NCT06637644 is a clinical study titled "Impella RP Flex with Smart Assist". To capture observational data of the Abiomed Impella RP Flex in a real-world setting.
What is the current status of trial NCT06637644?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-05-29. Estimated completion is 2026-06-01.
What conditions does trial NCT06637644 study?
This clinical trial studies the following conditions: Right Ventricular (RV) Dysfunction.
What interventions are being tested in trial NCT06637644?
The interventions under investigation include: Right-sided ventricular assist device (DEVICE).
Who is sponsoring clinical trial NCT06637644?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06637644 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI